Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H18N2O2 |
Molecular Weight | 270.3263 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC(=C1)C#CCO\N=C2/C[N@]3CC[C@@H]2C3
InChI
InChIKey=FXBXWJPMXQHOGD-UVTIVQHFSA-N
InChI=1S/C16H18N2O2/c1-19-15-6-2-4-13(10-15)5-3-9-20-17-16-12-18-8-7-14(16)11-18/h2,4,6,10,14H,7-9,11-12H2,1H3/b17-16+/t14-/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
149929-39-5
Created by
admin on Sat Dec 16 11:25:38 GMT 2023 , Edited by admin on Sat Dec 16 11:25:38 GMT 2023
|
PRIMARY | |||
|
2A2XC2CE1G
Created by
admin on Sat Dec 16 11:25:38 GMT 2023 , Edited by admin on Sat Dec 16 11:25:38 GMT 2023
|
PRIMARY | |||
|
PD-151832
Created by
admin on Sat Dec 16 11:25:38 GMT 2023 , Edited by admin on Sat Dec 16 11:25:38 GMT 2023
|
PRIMARY | PD 151832, a potent and selective muscarinic M1 receptor agonist, has shown promise as a cognition enhancing agent. PD 151832 was undergoing preclinical. | ||
|
9795428
Created by
admin on Sat Dec 16 11:25:38 GMT 2023 , Edited by admin on Sat Dec 16 11:25:38 GMT 2023
|
PRIMARY |
ACTIVE MOIETY